Lv41
470 积分 2023-09-11 加入
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
3小时前
已完结
Reactivation of mammalian regeneration by turning on an evolutionarily disabled genetic switch
3个月前
已完结
皖公网安备34019202002308
